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Mutant human interleukin-la proteins were constructed by oligonucleotide directed mutagenesis. Six different mutants 
were tested for receptor binding activity and showed no alteration with respect o the wild-type protein. Analysis of these 
mutants by nuclear magnetic resonance spectroscopy confirmed the structural integrity of the mutant proteins and pcr- 
mitted the sequence specific assignment of the histidine and tryptophan residues. 
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1. INTRODUCTION 
Interleukin-1 (IL-l) activity (reviews [1,2]) is 
mediated by two distinct 17 kDa proteins, IL-la 
and IL-l/Y, which, despite their limited amino acid 
homology, both bind to the same receptor [3,4]. 
The purification and characterization of recombi- 
nant human IL-la and IL-I,8 have been described 
[5,6]. To determine which regions of the protein 
are important for receptor interaction, a series of 
point mutations has been introduced into both 
proteins by site directed mutagenesis. In the case of 
IL-1,8, these mutant proteins have been in- 
vestigated by nuclear magnetic resonance (NMR) 
[7], and receptor binding studies have been carried 
out in conjunction with an assessment of the mu- 
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tant conformations in comparison with the wild- 
type protein [8]. 
In this paper we describe an analogous study on 
IL-la. Using two-dimensional NMR spectroscopy 
the conformation of two histidine mutants (at 
positions 46 and 127) and one tryptophan mutant 
(at position 139) is probed and sequence specific 
assignments for all the histidine and tryptophan 
resonances are obtained. In addition, we show that 
all mutants exhibit the same binding affinity for 
the IL-l receptor as wild-type IL-la. 
2. MATERIALS AND METHODS 
2.1. Preparation of wild-type and mutant IL-la 
Site-specific mutagenesis was used to introduce the point 
mutations in IL-la. The template was the phage Ml3 derivative 
mp8 carrying the coding region for mature IL-1~. Mutagenesis 
was carried out by the double-primer procedure [9] with 
oligonucleotides carrying one or two mismatches. After 
verification of the mutation by the dideoxy sequencing method 
[lo], the modified IL-la genes were transferred to a plasmid to 
be expressed under control of the APL promotor and the 
bacteriophage Mu ner gene ribosome binding site. The 
Escherichia cob host was W3110 ~1857, carrying the gene for 
the temperature sensitive repressor of phage A. Fermentation 
and protein purification procedures were as described [6]. 
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2.2. NMR spectroscopy 
Samples for NMR spectroscopy contained 1 mM protein in 
DrO containing 250 mM sodium phosphate buffer, 5 mM 
sodium azide, pH 7.5. All spectra were recorded on a Bruker 
AM 500 spectrometer equipped with digital phase shifters at 
25°C. Pure phase absorption two-dimensional Hartman-Hahn 
(HOHAHA) spectra [11,12] were recorded using the time pro- 
portional incrementation method [13,14]. 128 transients were 
collected for each of the 512 increments with a relaxation delay 
of 1 s between successive transients. The sweep width employed 
was 7042 Hz and the digital resolution in both dimensions, after 
zero-filling in the tl dimension only, was 6.88 Hz/point. 
2.3. IL-l receptor binding assay 
Competition binding was carried out using radioiodinated 
IL-la as described in detail [4,8]. 
3. RESULTS AND DISCUSSION 
The various mutants of human IL-la used in the 
present study are summarized in table 1 alongside 
the receptor binding data. The choice of mutants 
was based on the earlier observation that a His mu- 
tant of IL-lp, namely the His 30 + Arg substitu- 
tion, exhibited a marked decrease in receptor 
binding activity. We therefore carried out substitu- 
tions for all histidines present in the sequence of 
IL-la. As can easily be appreciated from the in- 
hibition data, there was no detectable difference 
between wild type IL-la and any of the mutant 
proteins. Thus, although IL-la and IL-l/3 bind to 
the same receptor, different amino acids may play 
a role in this interaction. 
In addition to the receptor binding studies we 
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Fig.1. 500 MHz ‘H-NMR spectra of IL-la and single amino 
acid substitution mutants at 25°C. 
Table 1 
Competition binding analysis of IL-la point mutants 
Mutant Substitution % inhibition of ‘*‘I-IL-la binding 
variant 
0.1 ng/ml 1 ng/ml 10 ng/ml 100 ng/ml 
Wild type none 7.5 + 1.8 38.2 f 3.8 85.3 f 2.2 91.8 * 1.2 
Ml5 Hias - Ala 7.9 45.3 77.2 85.1 
M24 Hiti6 --+ Arg 0 40.5 72 82.4 
M27 HiSiis - Ala 8.5 15.4 77.5 91.0 
M29 His127 - Ala 16.0 41.7 86.2 91.0 
M30 Hisr2, -+ Arg 20.1 44.4 86.3 91.6 
Ml6 Trprrg - Phe 0 40.8 83.8 90.0 
The indicated concentrations of unlabeled IL-la or IL-la point mutants were mixed with r2’I- 
IL-la (1 ng/ml) prior to addition of 0.5 x lo6 EL4-6.1 thymoma cells. After 3 h at 4”C, 
bound “‘I-IL-la was measured by spinning the cells through an oil gradient. Data are 
presented as Vo inhibition of duplicate determinations relative to controls in the absence of 
competitor. Data for wild type IL-la represent the mean (+ 1 SD) of 3 independent 
experiments, whereas the mutants represent the mean of 2 experiments 
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carried out an NMR spectroscopic investigation to pH-titration of the wild-type and mutant pro- 
probe the conformation of the various mutants. teins permitted the determination of p& values for 
Fig.1 shows the one-dimensional 500 MHz ‘H- the three histidines. His 127, which gives rise to the 
NMR spectra of the wild-type protein and some lowest field resonances, has a fairly high p& of 
mutants. With the exception of the expected disap- 7.5, while His 46 and 116 have pKa values of 6.9. 
pearance of the His resonances in the aromatic The chemical shifts of the CeH and C&H of the im- 
region of the spectra for the His mutants and some idazole ring for all the histidines at pH 7.5 are in- 
shifts in the aromatic region for the Trp mutant, dicated in the two dimensional HOHAHA 
the overall appearance of the spectra is very spectrum shown in fig.2. This figure illustrates the 
similar. This clearly demonstrates the structural in- aromatic region of the wild-type spectrum (a) com- 
tegrity of all mutant proteins investigated. In par- pared to the spectrum of the Trp 139 - Phe mu- 
titular , the high field methyl region tant (b). The cross-peaks arise from direct and 
(0.5-l .O ppm), which contains upfield shifted relayed through-bond (scalar) connectivities. In 
resonances arising mainly from ring currents due the wild-type spectrum the spin system of Trp 139 
to the proximity of these protons to aromatic is marked below the diagonal and the cross-peaks 
residues, is almost identical for all spectra. This belonging to this amino acid are clearly missing in 
region is regarded as one of the fingerprints of the mutant spectrum. Above the diagonal in fig.2a 
local and global conformation and therefore sug- all nine Tyr spin systems are indicated. Apart from 
gests that no large conformational differences exist the missing Trp resonances in fig.2b, one can clear- 
between the wild-type and mutant proteins. The se- ly observe two cross-peaks which are shifted 
quence specific assignment of the three aromatic (marked by an asterisk), one of them belonging to 
histidine resonance spin systems was easily deduc- a Tyr residue. Thus, the Trp 139 - Phe substitu- 
ed from the missing resonances in the various mu- tion has a very localized deshielding effect on a 
tant spectra. structurally neighbouring Tyr residue which 
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Fig.2. Aromatic region of the pure phase absorption HOHAHA spectra of wild-type IL-la (a) and the Trp 139 - Phe mutant (b) 
at 25°C. Some spin system connectivities are indicated by connecting lines. In panel a Tyr spin systems are indicated above the diagonal 
and the Trp 139 spin system below. The His spin systems are indicated in panel b. The mixing times were 31 ms (a) and 39 ms (b). 
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manifests itself in the downfield shift of its 
resonances. All other resonances, however, show 
no detectable shifts relative to the wild-type 
spectrum. 
In conclusion, our present study on IL-k and 
mutants thereof clearly demonstrates that the 
variants investigated exhibit identical receptor bin- 
ding activity to the wild-type protein and also show 
no or very small conformational changes. A full 
structural investigation of IL-1~ by NMR is 
presently underway and will provide the basis for 
future mutational strategies to locate the receptor 
binding site. 
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